Use of lupinus albus conglutin gamma for the treatment of type ii diabetes
CA 2515607 C · Owner: Morazzoni, Paolo · Inventors: Morazzoni, Paolo; Duranti, Marcello
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention discloses the use of lupin (lupinus albus) conglutin gamma , or of proteins showing homology higher than 50% with lupin conglutin gamma for the preparation of a medicament, food supplements or foods for the treatment , of type II diabetes, pharmaceutical and nutritional compositions containing lupin , conglutin gamma, and the use of lupin conglutin gamma as therapeutical agent in , particular as hypoglycemizing agent. Lupin conglutin gamma may be used in pure form or in form of extracts, mixtures or concentrates.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 6, 2004 and granted October 15, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended February 6, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 6, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.